The Ohio State University Human Nutrition Laboratory
Columbus, Ohio, 43210, United States
NCT Number: NCT05199948
The research study is a parallel arm, randomized placebo-controlled clinical trial designed to assess changes in hepatic lipid accumulation, visceral adipose tissue and postprandial lipid, markers of inflammation and energy metabolism in participants who consume 3 study foods per day for 16 week, while maintaining their body weight.
This study is active but is not currently recruiting participants.
22 year–80 year
All sexes
Interventional
Not applicable
Columbus, Ohio, 43210, United States
The study objectives include:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Three food product containing 10g of soybean oil each will be consumed each day for a today of 30g of soybean oil consumed each day
Three food product containing 10g of palm oil each will be consumed each day for a today of 30g of palm oil consumed each day
Time frame: Week 0 and Week 16
To determine the impact of dietary soybean oil on ectopic liver fat measured through MRI
Time frame: Week 0 and Week 16
To determine the impact of dietary soybean oil on visceral adipose tissue measured through MRI
Time frame: Week 0 and Week 16
To evaluate the effect of soybean oil supplementation on postprandial lipid panel including total cholesterol, HDL-Cholesterol, LDL-Cholesterol, Triglycerides
Time frame: Week 0 and Week 16
To evaluate the effect of soybean oil supplementation on the postprandial IL-6, Tumor necrosis factor, and C-reactive protein in the blood
Time frame: Week 0 and Week 16
To evaluate the effect of soybean oil supplementation on postprandial indirect calorimetry or respiratory gas exchange
Time frame: Week 0 and Week 16
Use multiple linear regressions to determine the association of change in plasma linoleic acid with changes in ectopic liver fat, visceral adipose, and postprandial total cholesterol, HDL-Cholesterol, LDL-Cholesterol, Triglycerides, L-6, Tumor necrosis factor, and C-reactive protein and indirect calorimetry
Time frame: Week 0 and Week 16
To determine the impact of dietary soybean oil on peripheral blood mononuclear cell cardiolipin species measured using electrospray ionization-mass spectrometry coupled to high-performance liquid chromatography
Time frame: Week 0 and Week 16
To determine the impact of dietary soybean oil on peripheral blood mononuclear cell mitochondria oxygen consumption rate using the seahorse assay
Ohio State University
Other
Weight, Energy, Lipids, and the Liver (WELL) Study: Dietary Fat Quality and Ectopic Lipids in the Liver
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06523530
Digestive System Diseases, Endometriosis
Thessaloniki, Greece
View Trial DetailsNCT04595474
Autoimmune Diseases, Cirrhosis, Liver
Boston, Massachusetts, United States
View Trial DetailsNCT07007741
Digestive System Diseases, Fatty Liver
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT05986916
Digestive System Diseases, Fatty Liver
La Jolla, California, United States
View Trial Details